Sep 10, 2026 08:30AM
Aug 24, 2026 08:30AM
Aug 24, 2026 08:30AM
Aug 12, 2026 04:05PM
Jun 18, 2026 08:02AM
Jun 18, 2026 08:00AM
Jun 5, 2026 08:01AM BioCardia receives FDA confirmation for CardiAMP trial pathway
Jun 5, 2026 08:00AM
May 28, 2026 08:06AM
May 28, 2026 08:00AM
May 21, 2026 08:02AM
May 21, 2026 08:00AM
May 15, 2026 08:00AM
May 8, 2026 08:01AM BioCardia receives FDA guidance on two approval pathways for Helix catheter
May 8, 2026 08:00AM
Apr 28, 2026 08:01AM
Apr 28, 2026 08:00AM
Apr 20, 2026 08:04AM
Apr 20, 2026 08:00AM
Apr 2, 2026 10:11AM
Apr 2, 2026 10:11AM BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP® System in Ischemic Heart Failure
Mar 24, 2026 04:05PM
Mar 17, 2026 06:01AM
Mar 17, 2026 06:00AM
Mar 3, 2026 08:00AM
Feb 10, 2026 09:15AM
Feb 10, 2026 09:15AM
Feb 3, 2026 08:00AM BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT)
Dec 16, 2025 08:00AM
Dec 3, 2025 08:01AM
Dec 3, 2025 08:00AM
Nov 12, 2025 04:40PM
Nov 10, 2025 08:30AM
Nov 10, 2025 08:30AM
Oct 30, 2025 08:01AM BioCardia enrolls first patient at University of Wisconsin in phase 3 trial
Oct 30, 2025 08:00AM
Sep 18, 2025 07:00AM
Sep 18, 2025 07:00AM
Sep 4, 2025 09:00AM
Aug 13, 2025 08:00AM
Aug 11, 2025 09:15AM
Aug 4, 2025 06:00AM BioCardia outlines regulatory timeline for heart therapy approvals
Aug 4, 2025 06:00AM
Jul 24, 2025 09:02AM
Jul 24, 2025 09:00AM
Jul 16, 2025 08:45AM
May 14, 2025 04:05PM
May 6, 2025 08:00AM
May 1, 2025 09:00AM BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure
Apr 11, 2025 09:16AM

330,722 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All